Specialty code 173000000X · New York, NY
NPI
1760407084
Since 2006
Specialty
Specialty code 173000000X
Code 173000000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
66 Fort Washington Ave, Fort Washington Medicall Office
New York, NY, 10032
Phone (212) 927-0013
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$3.7M
33,631 prescriptions
Company payments, 2025
$502
From 10 companies
Medicare prescription drug claims, 2024
In 2024, the drug Luis A Vasquez prescribed most often to Medicare patients was Omeprazole, with 1,493 prescriptions and refills. In total Luis A Vasquez wrote 33,631 Medicare prescriptions that cost $3.7M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-04-08.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Omeprazole Generic | 1,493 | 2,539 | 305 | $16K |
| Gabapentin Generic | 1,252 | 2,140 | 270 | $7,850 |
| Amlodipine Besylate Generic | 1,247 | 2,287 | 252 | $5,188 |
| Simvastatin Generic | 1,163 | 2,250 | 253 | $5,081 |
| Memantine Hcl Generic | 779 | 1,297 | 158 | $9,979 |
| Metformin Hcl Generic | 730 | 1,300 | 151 | $14K |
| Diclofenac Sodium Generic | 707 | 800 | 129 | $121K |
| Atorvastatin Calcium Generic | 674 | 1,354 | 161 | $6,565 |
| Escitalopram Oxalate Generic | 659 | 1,036 | 128 | $3,477 |
| Mirtazapine Generic | 658 | 1,114 | 142 | $11K |
| Alendronate Sodium Generic | 651 | 1,132 | 134 | $2,329 |
| Folic Acid Generic | 647 | 1,166 | 171 | $556 |
| Rosuvastatin Calcium Generic | 616 | 1,193 | 138 | $5,713 |
| Meclizine Hcl Generic | 599 | 969 | 125 | $5,262 |
| Celecoxib Generic | 598 | 828 | 125 | $6,381 |
Brand drugs: 4,793 claims; generic drugs: 27,761 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Luis A Vasquez $502 ($502 in general payments such as food, travel and fees) from 10 companies. The largest payer was Amgen Inc. with $97.09.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 5 | $97.09 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 4 | $96.39 |
| Abbvie Inc. ABBV | 4 | $77.84 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 3 | $66.98 |
| Lilly USA, LLC LLY | 2 | $47.08 |
| Pfizer Inc. PFE | 1 | $31.5 |
| Phathom Pharmaceuticals, Inc. PHAT | 1 | $28.67 |
| Shield Therapeutics Inc STX.L | 1 | $22.07 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $17.41 |
| GlaxoSmithKline, LLC. GSK | 1 | $16.84 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.